Blog

Sep 30, 2023

Insilico uses Microsoft’s BioGPT to find targets for aging and disease

Posted by in categories: biotech/medical, life extension, robotics/AI

Insilico Medicine, a clinical-stage generative AI-driven drug discovery company has announced that the company has used Microsoft BioGPT to identify targets against both the aging process and major age-related diseases.

Longevity. Technology: ChatGPT – the AI chatbot – can craft poems, write webcode and plan holidays. Large language models (LLMs) are the cornerstone of chatbots like GPT-4; trained on vast amounts of text data, they have been contributing to advances in diverse fields including literature, art and science – but their potential in the complex realms of biology and genomics has yet to be fully unlocked.

Comments are closed.